<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>VentureBeat - Latest Comments in InCode BioPharmaceutics raises $2M to target autoimmunity</title><link>http://venturebeat.disqus.com/</link><description>News about Tech, Business and Innovation</description><atom:link href="https://venturebeat.disqus.com/incode_biopharmaceutics_raises_2m_to_target_autoimmunity/latest.rss" rel="self"></atom:link><language>en</language><lastBuildDate>Tue, 08 Jan 2013 07:04:51 -0000</lastBuildDate><item><title>Re: InCode BioPharmaceutics raises $2M to target autoimmunity</title><link>http://venturebeat.com/2007/06/15/incode-biopharmaceutics-raises-2m-to-target-autoimmunity/#comment-759917827</link><description>&lt;p&gt;Lets see how they will make use of these fundings, not many people are aware of autoimmune diseases this is why they don't give attention to symptoms like chronic headaches, continuous pain in joints and fatigue, it is better to visit a doctor in such situations.&lt;/p&gt;</description><dc:creator xmlns:dc="http://purl.org/dc/elements/1.1/">Ronald Craig</dc:creator><pubDate>Tue, 08 Jan 2013 07:04:51 -0000</pubDate></item></channel></rss>